![Paul W. Finnegan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul W. Finnegan
Directeur Général chez
Angiocrine Bioscience, Inc.
Profil
Paul W.
Finnegan currently works at Angiocrine Bioscience, Inc., as Chief Executive Officer & Director from 2015 and American Society of Hematology, as Member.
Dr. Finnegan also formerly worked at Pharmacia Corp., as Senior Director-Global Medical Marketing, Toronto East General Hospital Foundation, as Director & Partner from 1993 to 1997, Harrow, Inc., as Independent Director from 2012 to 2013, and Alexion Pharmaceuticals, Inc., as VP-Global Strategic Marketing & Development from 2001 to 2007.
Dr. Finnegan received his doctorate degree from McGill University and Masters Business Admin degree from The University of Chicago.
Postes actifs de Paul W. Finnegan
| Sociétés | Poste | Début |
|---|---|---|
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Directeur Général | 01/05/2015 |
Anciens postes connus de Paul W. Finnegan
| Sociétés | Poste | Fin |
|---|---|---|
| HARROW, INC. | Directeur/Membre du Conseil | 01/10/2013 |
| ALEXION PHARMACEUTICALS, INC. | Sales & Marketing | 01/09/2007 |
Toronto East General Hospital Foundation | Directeur/Membre du Conseil | 01/01/1997 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Sales & Marketing | - |
Formation de Paul W. Finnegan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Commercial Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Toronto East General Hospital Foundation | |
Harrow, Inc.
 Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Choisissez Zonebourse 
